Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2021

Jun 15, 2021

31046_dirs_2021-06-15_6024d507-42a1-413b-abac-1af416bf4162.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-06-08

Reporting Person: Smith Mary L. (Director)